- Home
- BNBX vs CMND Comparison
BNBX vs CMND Comparison
Compare BNBX & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNBX | CMND |
|---|---|---|
| Founded | 1983 | 2017 |
| Country | United States | Canada |
| Employees | 26 | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9M | 2.6M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | BNBX | CMND |
|---|---|---|
| Price | $0.37 | $2.30 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 95.2K | ★ 994.3K |
| Earning Date | 05-14-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $253.12 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.32 | $0.07 |
| 52 Week High | $6.17 | $4.66 |
Technical Indicators
Market Signals| Indicator | BNBX | CMND |
|---|---|---|
| Relative Strength Index (RSI) | 38.58 | 42.76 |
| Support Level | $0.35 | $1.74 |
| Resistance Level | $0.85 | $2.76 |
| Average True Range (ATR) | 0.04 | 0.27 |
| MACD | -0.01 | -0.20 |
| Stochastic Oscillator | 27.46 | 12.78 |
Price Performance
Historical ComparisonAbout BNBX Applied DNA Sciences Inc.
BNB Plus Corp focuses on digital asset treasury management of BNB. The group is unlocking institutional-grade access to the Binance ecosystem, delivering non-directional yield strategies and long BNB exposure, powering the future of blockchain through a transparent, actively managed BNB treasury. The Company's differentiated blends sophisticated DeFi yield generation with Binance-native opportunities, unlocking access to high-performance digital assets for investors traditionally excluded from the space.
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.